http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4095247-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb6372dde89a8ac6af866c273e9f3f8f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24243
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2020-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e31eec68ebca8c9e0632ab7471ba1dc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b950f59dd513331a4be59a48daab274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94532a376e87c5886f09d1b10cef6a6a
publicationDate 2022-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4095247-A1
titleOfInvention Screening system for therapeutic agent for coronavirus infection
abstract The present invention relates to a screening composition for a therapeutic agent for coronavirus infection, comprising a CoV RdRp expression vector and a bicistronic reporter vector, a screening kit for a therapeutic agent for coronavirus infection, comprising the composition, and a method for screening a therapeutic agent for coronavirus infection using the composition or kit. When the screening composition for a therapeutic agent for coronavirus infection, provided by the present invention, is used, candidate materials that can have direct influences on the activity of CoV RdRp can be screened more quickly and easily, and thus, the composition can be widely used in the development of therapeutic agents for coronavirus infection.
priorityDate 2020-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21690862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19816131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429446

Total number of triples: 49.